Evidence map›Paper›PMID 37563352›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2023

Strategy planning for turbulent times in nuclear medicine: Time to begin at the beginning?

Rayjanah Allie, Irfan Kayani, Gopinath Gnanasegaran, Sobhan Vinjamuri, Arturo Chiti, Diana Paez, Francesco Giammarile, Ken Herrmann, Jamshed Bomanji

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rayjanah AllieInstitute of Nuclear Medicine, University College London Hospital, 5Th Floor, 235 Euston Road, London, NW1 2BU, UK.
Irfan KayaniInstitute of Nuclear Medicine, University College London Hospital, 5Th Floor, 235 Euston Road, London, NW1 2BU, UK.
Gopinath GnanasegaranInstitute of Nuclear Medicine, University College London Hospital, 5Th Floor, 235 Euston Road, London, NW1 2BU, UK.
Sobhan VinjamuriRoyal Liverpool University Hospital, Liverpool, UK.
Arturo ChitiFaculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
Diana PaezNuclear Medicine and Diagnostic Imaging Section, Department of Nuclear Sciences and Applications at the International Atomic Energy Agency (IAEA), Vienna, Austria.
Francesco GiammarileNuclear Medicine and Diagnostic Imaging Section, Department of Nuclear Sciences and Applications at the International Atomic Energy Agency (IAEA), Vienna, Austria.
Ken HerrmannDepartment of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Jamshed BomanjiInstitute of Nuclear Medicine, University College London Hospital, 5Th Floor, 235 Euston Road, London, NW1 2BU, UK. jamshed.bomanji@nhs.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Nuclear MedicineHumansRadionuclide Imaging

Identifiers

PMID37563352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.